心脏微环境在心血管疾病中的作用:对治疗的影响
Jiayu Yao1, Yuejun Chen1, Yuqing Huang1
1School of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China.
Human cell
|March 18, 2024
概括
心血管疾病源于衰老和生活方式的变化,影响心脏组织的平衡. 了解细胞相互作用和心脏环境为新型干细胞和针对这些疾病的向治疗提供了新的见解.
科学领域:
- 心脏病学 心脏病学
- 细胞生物学 细胞生物学
- 病理生理学 病理生理学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,因衰老和生活方式而恶化.
- 心脏包括多种细胞类型 (心肌细胞,纤维细胞,内皮细胞,光滑肌肉,免疫细胞),对其功能至关重要.
- 心脏组织平衡依赖于细胞专业化和细胞间通信.
研究的目的:
- 审查心脏组织的组成和恒温.
- 探索心脏微环境在心血管疾病发病过程中的作用.
- 讨论心血管疾病的新型治疗策略.
主要方法:
- 文献综述侧重于心脏组织组成和平衡.
- 对心血管疾病发展背后的分子机制的分析.
- 检查新兴的治疗方法,如干细胞和向疗法.
主要成果:
- 功能障碍的细胞和心脏微环境的改变与心血管疾病有关.
- 复杂的细胞相互作用对于保持心脏健康至关重要.
- 新的治疗方法在治疗心血管疾病方面表现有前途.
结论:
- 了解心脏细胞相互作用和微环境是预防和治疗心血管疾病的关键.
- 干细胞疗法和向治疗是心血管疾病管理的有希望的途径.
- 对这些领域的进一步研究可能会揭示新的预防策略和治疗目标.
相关概念视频
Pathophysiology of Cardiac Performance
645
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
645
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


